Reproductive decisions made by balanced chromosome translocation carriers

Genome-wide cfDNA sequencing in cancer patients

Labcorp appoints Dr. Deborah Ann Sesok-Pizzini as chief medical officer, Labcorp Diagnostics

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 19, 2021-- Labcorp , (NYSE: LH), a leading global life sciences company, announced today that Dr. Deborah Ann Sesok-Pizzini has been appointed Chief Medical Officer of Labcorp Diagnostics , following the retirement of Dr. Dot Adcock in April 2021 . Dr. Sesok-Pizzini assumed the role starting on January 11, 2021.

Media Statement: Labcorp political contributions

Labcorp does not make contributions to federal political candidates. 

Media Statement: Tracking mutations of the SARS CoV2

We have been regularly tracking mutations of the virus throughout the pandemic to determine the impact it would have on our PCR sensitivity. To date, we have not seen any impact. Our current capacity for PCR tests is 270k and we continue to operate with a 1-2 day turnaround. The only way to identify the strain is by sequencing, and we have research support underway that includes sequencing of the virus.